Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-Ying Pan

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Research|March 29, 2013
Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapySamuel Eisenstein, Brian A Coakley, Karen Briley-Saebo, et al.
Cancer Research Communications|August 1, 2022
World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostatesLin Wang, Yitian Xu, Licheng Zhang, et al.
Cell Death & Disease|May 21, 2022
Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling studyJoseph D Butner, Prashant Dogra, Caroline Chung, et al.
Journal of Functional Biomaterials|April 27, 2026
Potentiation of a Porous Silicon Therapeutic Vaccine in Colorectal Cancer via Oxaliplatin-Mediated Regulation of Myeloid-Driven ImmunosuppressionYongbin Liu, Busra Akay Hacan, Junjun Zheng, et al.
Advanced Therapeutics|December 13, 2021
Virus-Mimic mRNA Vaccine for Cancer TreatmentChaoyang Meng, Zhe Chen, Junhua Mai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2015
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body RadiotherapyHui-Ming Chen, Ge Ma, Neil Gildener-Leapman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2023
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung CancerJian Guan, Kai Sun, Carlo A Guerrero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
The EMBO Journal|February 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4Yitian Xu, Kyeongah Kang, Brian A Coakley, et al.
Cancer Research|December 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell TherapySunny Mai, Alan Hodges, Hui-Ming Chen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Research|March 29, 2013
Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapySamuel Eisenstein, Brian A Coakley, Karen Briley-Saebo, et al.
Cancer Research Communications|August 1, 2022
World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostatesLin Wang, Yitian Xu, Licheng Zhang, et al.
Cell Death & Disease|May 21, 2022
Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling studyJoseph D Butner, Prashant Dogra, Caroline Chung, et al.
Journal of Functional Biomaterials|April 27, 2026
Potentiation of a Porous Silicon Therapeutic Vaccine in Colorectal Cancer via Oxaliplatin-Mediated Regulation of Myeloid-Driven ImmunosuppressionYongbin Liu, Busra Akay Hacan, Junjun Zheng, et al.
Advanced Therapeutics|December 13, 2021
Virus-Mimic mRNA Vaccine for Cancer TreatmentChaoyang Meng, Zhe Chen, Junhua Mai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2015
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body RadiotherapyHui-Ming Chen, Ge Ma, Neil Gildener-Leapman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2023
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung CancerJian Guan, Kai Sun, Carlo A Guerrero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
The EMBO Journal|February 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4Yitian Xu, Kyeongah Kang, Brian A Coakley, et al.
Cancer Research|December 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell TherapySunny Mai, Alan Hodges, Hui-Ming Chen, et al.
Pageof 5